Daré Bioscience, Inc.
DARE
$2.04
-$0.04-1.92%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 8.26% | 20.49% | -17.10% | -136.42% | 291.12% |
| Total Depreciation and Amortization | 191.02% | 2,370.31% | -34.02% | -37.01% | 42.59% |
| Total Amortization of Deferred Charges | -133.71% | -- | -- | -- | 2,928.57% |
| Total Other Non-Cash Items | 27.17% | -33.60% | 7.20% | -7.41% | -48.22% |
| Change in Net Operating Assets | -40.99% | -117.57% | 621.21% | -144.77% | 47.77% |
| Cash from Operations | 0.97% | -204.67% | 188.23% | -145.91% | 289.41% |
| Capital Expenditure | 197.52% | 72.05% | -299.36% | 198.98% | -3,806.85% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 197.52% | 72.05% | -299.36% | 198.98% | -3,806.85% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -178.47% | 0.00% | -50.00% | -86.83% | 66.67% |
| Issuance of Common Stock | 8.90% | 685.95% | -- | -100.00% | -14.92% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 200.00% | -733.33% | 25.00% | 50.00% | -14.29% |
| Cash from Financing | -117.76% | 286.82% | -130.25% | 278.16% | 724.29% |
| Foreign Exchange rate Adjustments | -1.53% | 119.79% | -389.08% | 56.85% | 137.24% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.36% | -220.21% | 186.17% | -140.65% | 286.24% |